U.S. Obesity Rate Drops As GLP-1 Usage Grows
The post U.S. Obesity Rate Drops As GLP-1 Usage Grows appeared on BitcoinEthereumNews.com. Topline About one in nine Americans take a GLP-1 medication for weight loss, results from a new Gallup poll released on Tuesday found—a staggering rise over the past two years as the obesity rate in the U.S. continues to decline from a record high in 2022. A new Gallup poll found about 11% of Americans were taking a GLP-1 medication for weight loss. UCG/Universal Images Group via Getty Images Key Facts A record high 11% of Americans are taking a GLP-1 medication for weight loss, according to Gallup, up 3% from 2024. At the same time, Gallup points out the obesity rate among Americans fell to 36.4% in 2026, down from a record high of 39.9% in 2022, the year after GLP-1 medication Wegovy was first approved by the Food and Drug Administration to treat weight loss. The diabetes rate has also remained flat for the past few years, according to Gallup’s data. 68% of GLP-1 users reported taking a name br